Mannkind Corp

Research Mannkind Corp (MNKD) on Bullrun: market cap USD 1.31B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMNKD
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.31B
• Financial periodFY2025
• RevenueUSD 348.97M
• Revenue growth22.2%
• Net incomeUSD 5.86M
• Free cash flowUSD 13.69M
• Gross margin92.3%

Valuation Snapshot

latest market cap is USD 1.31B.

About Mannkind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve glycemic control in adults with diabetes;

Frequently asked questions

What is Mannkind Corp's market cap?

Mannkind Corp's market capitalization is USD 1.31B.

What does Mannkind Corp do?

MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care.